Sanofi to demonstrate how they have overcome market access challenges in Turkey

SMi's 21st annual European Pharmaceutical Pricing and Reimbursement conference, taking place on 5-6 October 2015 in London, will address market access challenges and details how to overcome them with case studies from MSD, Sanofi, GSK and more.
By: SMi Group
 
 
200x200-European-Pharmaceutical-Pricing-and-Reimbu
200x200-European-Pharmaceutical-Pricing-and-Reimbu
LONDON - Aug. 17, 2015 - PRLog -- SMi’s 21st annual European Pharmaceutical Pricing and Reimbursement conference will provide the ideal platform for payers and other decision makers from both public and private organisations, to benchmark with peers internationally and provide pharma companies with an invaluable insight into the decision making processes and approaches of vital stakeholders. The two-day conference programme will help further your understanding and enable you to develop best practice approaches to complex market access and pricing challenges, with the ultimate goal of encouraging innovation and improving patient access to novel and powerful medications. Unique insight will be provided on:
• Case studies assessing of the impact Biosimilars and Orphan Drugs on the the market with MSD and Quintiles
• Tiered pricing options with a case study from GSK
• Case studies in Reforms with Sanofi sharing their perspective
• Evaluating new models for European reimbursement
• Health Technology Assessment policies
• Changes in UK P&R policy following the UK elections with presentations from industry bodies such as EMIG and the ABPI

Furthermore, we are delighted to announce that Sanofi's Head of Market Access and Health Economics, Toros Sahin, will be leading a presentation titled ‘Market Access in Turkey: Risks and opportunities in the post Healthcare Transformation Era’ at SMi's European Pharmaceutical Pricing & Reimbursement conference on Day 2. He will be sharing his insight on the following topic areas:
• Overview of Turkish Market Access & Healthcare Environment
• Basics of the Turkish Pricing & Reimbursement System
• Changing dynamics of the reimbursement system: Alternative models
• Government’s mid-long term vision on pharmaceutical industry

Speaker Panel includes:
• Leslie Galloway, Chairman, Ethical Medicines Industry Group
• Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs
• Janice Haigh, Practice Leader Market Access, Quintiles
• David Watson, Director of Pricing & Reimbursement, ABPI
• Ken Walsh, Head of Emerging Markets Pricing, GSK
• Toros Sahin, Head of Market Access & Health Economics, Sanofi Turkey
• Alexander Roediger, Director European Union Affairs, MSD
• Leyla Hannbeck, Head of Pharmacy, National Pharmaceutical Association Ltd
• Eric Low, CEO, Myeloma UK
• Maggie Dolan, Regional Pharmacy Procurement Specialist, NHS Commercial Solutions

To view the full speaker line-up and conference programme, visit http://www.smi-online.co.uk/2015europricing1.asp

Plus, don't miss the half-day interactive post-conference workshop:
HTA Uncovered
Led by: Anke Van Engen, Principal - Advisory Services & Janice Haigh, Practice Leader Market Access, Quintiles
7th October 2015 | 8.30 – 12.30

Contact
SMi Group
***@smi-online.co.uk
End
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Pharmaceuticals, Health, Economics
Industry:Health
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share